medicamentos
The Diplomat | 17-oct-2017
The RCEP has hidden costs for people’s lives
APWLD | 14-oct-2017
RCEP will give multinational corporations unprecedented rights
Interfax | 18-sep-2017
Sanofi Aventis Ukraine LLC, part of Sanofi global pharmaceutical company, seeks to file a claim against Ukraine to the International Investment Arbitration.
Forbes India | 12-sep-2017
The first ever final award on patents in international investment arbitration by ICSID in the case of Eli Lilly v. Canada has effectively cleared the way for raising future disputes by foreign IPR owners against domestic institutions which can result in stronger and robust IP protection regime.
Asian Tribune | 24-jul-2017
Officials from ASEAN member states and other countries meeting in India this week for negotiations on the Regional Comprehensive Economic Partnership (RCEP) should take steps to ensure that the trade deal safeguards human rights, Southeast Asian lawmakers said today.
Info Justice | 14-jul-2017
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
APWLD | 13-jul-2017
The ’No RCEP’ campaign urges governments to consider the adverse impact of the mega free trade agreement
Focus on the Global South | 1ro-jun-2017
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
Inquirer.net | 18-may-2017
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
People Over Profit | 12-may-2017
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership

0 | 10 | 20 | 30 | 40